GPC6 and lung cancer: Consistent with this notion, it has been shown that MALAT1 depletion in lung cancer cells could significantly reduce the expression levels of Glypican 6 and C‐X‐C motif chemokine 5 to block signalling transduction upstream of ERKs 22.